DXCOVER
It is our mission to be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life. Dxcover are an award-winning team, dedicated to developing liquid biopsies for early detection of cancer and other diseases. A University of Strathclyde spinout in 2019 under the name ClinSpec Diagnostics, and rebranded as Dxcover Limited in 2021. To date, Dxcover have secured £5.1m of funding, and have successfully completed two ground-breaking clinical studies on detection of brain cancer and are currently developing our platform for the detection of commonly occurring cancers.
DXCOVER
Industry:
Biotechnology Health Care Health Diagnostics Machine Learning Medical Medical Device
Founded:
2016-01-01
Address:
Glasgow, Glasgow City, United Kingdom
Country:
United Kingdom
Website Url:
http://www.dxcover.com
Total Employee:
11+
Status:
Active
Total Funding:
6.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content COVID-19 Wix
Similar Organizations
1928 Diagnostics
Fighting antibiotic resistance with DNA analytics
Abtrace
AI based solutions that scale medical expertise.
Aidence
Aidence provides AI solutions for the lung cancer pathway.
Aktiia
AI-driven insights for a novel understanding and care of Hypertension
Concepta Diagnostics
Women's Health Diagnostic Company
Concr
Solving data to enable precision diagnostics for all.
Czur scanner
The Czur is a sort of camera/scanner hybrid
D-EYE
D-EYE provides portable eye and retinal imaging system.
De Lune
The New Age of Period Health
Ectosense
Sleep disorder diagnostics
Elephas
A live tumor imaging diagnostics company
Expeda
Expeda produces quality medical bioinformatics diagnostic tools.
Fastbase Solutions
Fastbase Solutions is a cancer diagnostics platform.
Fourier Intelligence
Fourier Intelligence is a Technology and design company
GNA Biosolutions
GNA Biosolutions is a private molecular diagnostics company.
Hutom
Reshaping Surgery Through Digital Innovation
Ilara Health
Affordable technology-powered diagnostics for Africa
iLoF - Intelligent Lab on Fiber
iLoF - Intelligent Lab on Fiber is enabling a new era of personalized, precision medicine.
inContAlert Technologies
The hearing aid for incontinence.
Inno-Gene
The project of reading human genome
iXensor
The pioneer of mobile health
Kāhu
Kāhu is the Kiwi AI cancer-detection startup.
Lambda Health System
Lambda Health System is a spin-off of the University
Lucid Group
Lucid aims to develop a unique 3 in one diagnostic device.
Medical Imaging Partnership
UK-based provider of medical diagnostic imaging services.
MedicaMetrix
Advancing Prostate Disease Management
Moichor
The next generation of animal diagnostics.
Mologic
Mologic is a UK-based developer of point-of-care diagnostic devices
Mursla
Novel multi-omics exosome characterisation company.
NuProbe
NuProbe is a cutting-edge genomics and molecular diagnostics company.
Nutrix
Reshaping the future of healthcare
Omniscope
We read your immune system to intercept diseases.
Orange Health
Orange Health is a HealthTech startup that allows doctors to deliver diagnostic lab services to patients remotely.
Paige
A Global Leader in Digital Diagnostics
Pre Diagnostics
Pre Diagnostics is an innovative Norwegian diagnostic company
Protean BioDiganostics Inc
Precision Oncology and Diagnostics
Pulsewave
Pulsewave is transforming Eyewear into Cardio Biomarker monitoring wearables.
Quantum_AI Advanced Health-Care Solutions
The Future of Health-Care
QV Bioelectronics
Longer, Better Quality Lives for Brain Tumour Patients
RSP Systems A/S
Non-Invasive Glucose Monitoring and other Non-Invasive Diagnostics
Sanome
Transforming diagnostics for all
Scanbo
Democratizing Access To Medical Diagnostics
Mediktor
The most advanced and accurate sypmtom checker
Wecancer
Wecancer provides a monitoring platform for cancer patients.
Current Employees Featured
David S Palmer Co-Founder, Director, and Chief Data Officer @ Dxcover
Co-Founder, Director, and Chief Data Officer
2019-02-01
Founder
Investors List
University of Strathclyde
University of Strathclyde investment in Seed Round - Dxcover
Norcliffe Capital
Norcliffe Capital investment in Seed Round - Dxcover
Eos Advisory
Eos Advisory investment in Seed Round - Dxcover
Eos Advisory
Eos Advisory investment in Seed Round - Dxcover
Scottish Investment Bank
Scottish Investment Bank investment in Seed Round - Dxcover
Mercia Asset Management
Mercia Asset Management investment in Seed Round - Dxcover
University of Strathclyde
University of Strathclyde investment in Seed Round - Dxcover
SIS Ventures
SIS Ventures investment in Seed Round - Dxcover
Scottish Investment Bank
Scottish Investment Bank investment in Seed Round - Dxcover
Mercia Fund Managers
Mercia Fund Managers investment in Seed Round - Dxcover
Official Site Inspections
http://www.dxcover.com
- Host name: 231.107.209.35.bc.googleusercontent.com
- IP address: 35.209.107.231
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Dxcover"
Dxcover | The Future of Cancer Diagnostics
Dxcover is a multi-omic platform revolutionizing early cancer detection for multiple cancers powered by light and machine learning.See details»
Dxcover - Crunchbase Company Profile & Funding
Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.See details»
Leadership - Dxcover
Mark led Dxcover as CEO for the first five-year plan from spin-out. 25+ years experience in health care innovation, spanning start-ups, SMEs, and multi-nationals. Formerly Managing …See details»
About - Dxcover
Dxcover aims to be a world leader in liquid biopsy and artificial intelligence for early detection of cancers to improve survival and quality of life.See details»
Dxcover - Wikipedia
Dxcover has developed 'Drop, Dry, Detect' technology which technically detects and works in minutes to detect signs of cancer using artificial intelligence trained model. Panoramic platform is a multi-omic spectral analysis (MOSA) technology for various cancers which are brain, advanced adenoma, colorectal, and lung cancer. This technology analyses the signals that were missed by traditional cancer detection methods. See details»
DXCOVER LIMITED overview - Find and update company …
DXCOVER LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»
DXCOVER LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DXCOVER LIMITED of GLASGOW. Get the latest business insights from Dun & Bradstreet.See details»
Dxcover - Contacts, Employees, Board Members, Advisors & Alumni
Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.See details»
Dxcover - SIS Ventures
Dxcover is an ambitious mission-led business that has developed a way of detecting cancer at an early stage using a simple to undertake blood test. Its mission is to be a world leader in liquid …See details»
Dxcover - Funding, Financials, Valuation & Investors
Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.See details»
Dxcover Accelerates Growth With New Funding Round and …
Feb 3, 2025 Dxcover’s new blood test has the very real potential to improve people’s experience of cancer care by speeding up brain cancer diagnosis and supporting healthcare decision …See details»
Contact - Dxcover
Led by experts in diagnostics and champions of Dxcover’s Mission and Values.See details»
Dxcover Accelerates Growth With New Funding Round and
Feb 3, 2025 Dxcover Accelerates Growth With New Funding Round and Strengthens the Leadership Team - New capital raise from existing investors, as well as new investors, …See details»
Dxcover announces $6.2M funding round - Med-Tech Insights
Feb 3, 2025 Dxcover has announced its next key stage of growth with the closing of a funding round to drive innovation and expand its commercial presence.See details»
Dxcover Accelerates Growth With New Funding Round and
Feb 3, 2025 Dxcover’s unique AI algorithms are built on data; over 9000 patients and 250,000 spectra ensure robust diagnostic performance that can be tuned for high sensitivity or …See details»
Dxcover - Updates, News, Events, Signals & Triggers - Crunchbase
Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.See details»
Dxcover Accelerates Growth With New Funding Round and …
Feb 3, 2025 Dxcover’s unique AI algorithms are built on data; over 9000 patients and 250,000 spectra ensure robust diagnostic performance that can be tuned for high sensitivity or …See details»
Members · People · Dxcover · GitHub
This organization has no public members.GitHub is where Dxcover builds software.See details»
Newsroom - Dxcover
Invest in Dxcover News Newsroom Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact …See details»
News | Dxcover | Page 6 of 8
Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company has …See details»